|
FDA | CDER | Small Business and Industry Assistance (SBIA)
Global IDMP Implementation - Getting Closer to the Goal
|
|
|
October 16, 2024 | 1:00 PM - 2:30 PM ET
|
|
|
Identification of Medicinal Products (IDMP) offers a global framework for the unique identification and consistent documentation of medicinal products, facilitating effective information exchange among regulators, manufacturers, suppliers, and distributors. Once fully adopted, these standards will enhance pharmacovigilance, address drug shortages, and improve medication safety worldwide.
This webinar will present an overview of the end-to-end testing results for the Global Pharmaceutical Product Identification (PhPID) Service operating model, which generates global PhPIDs for marketed medicinal products. The session will detail the model's readiness for deployment, including its software functionality, interoperability, processes, and business rules. Additionally, results from simulated real-world scenarios across three global IDMP use cases—Pharmacovigilance, Drug Shortages, and Cross-border Healthcare—will be discussed.
|
|
CONTINUING EDUCATION (CE)
Real-time participation is required for the certificate of attendance, which can be used in support of CEs for the following professional organizations: RAPS, SOCRA, SQA, and ACRP. Certificates are only available during the two weeks post-event. For more information, see details on our webpage.
|
|
|
The Small Business and Industry Assistance (SBIA) program in the Center for Drug Evaluation and Research provides guidance, education and updates for regulated industry.
|
|
|
|
|
|
